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Supplementary Figure 1. Tumour core regions display heterogeneity. 
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Supplementary Figure 1 Tumour core regions display heterogeneity. (a) 
Schematic of tumour dissection. One unit equals 20% of the radius. (b) 
Schematic of PACT (defined as Passive CLARITY) Technique procedure. 
(c) 3D imaging of M229 xenograft tumour depicting H3K27me3 (red), 
Hif1α (orange) and KI67 (blue) staining. Periphery and core of tumour are 
as indicated. Scale bar = 250 mm. (d) Immunohistochemistry staining in 
xenograft tumours. Whole tumours were sliced and stained with indicated 
antibodies (cleaved caspase 3, HIF-1α). H&E staining is also shown. Scale 
bar = 80 mm. (e) Tissues from periphery and core regions of xenograft 
tumours were lysed to collect whole cell lysate. Proteins were assessed by 
western blotting with specified antibodies. Unprocessed original scans of 
blots are shown in Supplementary Fig. 8.
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Supplementary Figure 2. Histone methylation induced by low glutamine levels is not due to low proliferation rate of cells.
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Supplementary Figure 2 Histone methylation in low glutamine is not due to 
low proliferation rate of cells. (a) For lane 1 and 2, 50% confluent M229 
cells were cultured in complete (4mM glutamine) or 0.1mM glutamine 
medium for 4 days. For lane 3, 100% confluent M229 cells were cultured 
in complete medium for 4 days. Cells were lysed for histone extraction and 
histone lysine methylation levels were assessed by western blotting. Total 
histone H3 was used as loading control. Unprocessed original scans of blots 
are shown in Supplementary Fig. 8. (b) Cells were cultured under different 
conditions as indicated and cell number was determined by cell counting 
everyday (3T3 and Ras-3T3) or every other day (M229). Data represent 
mean ± S.D., n=3 independent experiments. (c) Cells were cultured 
under different conditions as indicated. After PI staining, cell survival was 
assessed by flow cytometry. Data represent mean ± S.D., n=3 independent 
experiments. Source data for b and c are shown in Supplementary Table 4.
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Supplementary Figure 3. Low glutamine is the major driver of histone methylation.
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Supplementary Figure 3 Low glutamine is the major driver of histone 
methylation.  (a,b) M229 cells were cultured under different conditions for 4 
days as indicated. After that, cells were lysed for histone extraction and histone 
lysine methylation levels were assessed by western blotting. Total histone H3 
was used as loading control. Unprocessed original scans of blots are shown 
in Supplementary Fig. 8. (c) M229 cell survival in low glucose medium. 
M229 cells were cultured in complete medium (25mM glucose) or medium 
with different glucose concentrations for 4 days. Medium was changed twice 
everyday. Cells were stained with PI and cell survival was measured by Flow 
cytometry. Data represent mean ± S.D., n=3 independent experiments.
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Supplementary Figure 4. Low glutamine  suppresses  differentiation genes and induces CD271. 
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Supplementary Figure 4 Low glutamine induces suppression of 
differentiation genes, which can be reversed by EPZ005687. (a) M249 
cells were cultured in complete or 0.1mM glutamine medium for 12 days, 
then RNA was extracted and gene expression was assessed by qPCR. 
Data represent mean ± S.D. of three independent RNA extracts. *P<.05, 
**P<.01, ***P<.001 by unpaired Student’s t-test. Source data can be 
found in supplementary Table 4. (b) M229 cells were stained with Alexa647 
conjugated CD271 antibody. Cells were then sorted by flow cytometry and 
CD271- cells were collected. (c) The CD271- cells were cultured for 2 days 
and then stained with APC conjugated CD133 antibody. The stained cells 
were sorted again and CD271-/CD133- cells were collected. (d) CD271-/
CD133- cells were cultured in complete (4mM Gln) or 0.1mM Gln medium 
for 4 days, then cells were harvested for histone extraction or whole cell 
lysate collection. Histone lysine methylation and protein levels were assessed 
by western blotting. Total histone H3 and Actin were used as loading control. 
Unprocessed original scans of blots are shown in Supplementary Fig. 8.
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Supplementary Figure 5. Low glutamine-induced differential gene expression is reversed by H3K27me3 inhibitor.
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Supplementary Figure 5 Low glutamine-induced differential gene expression 
is reversed by H3K27me3 inhibitor. (a,b) M229 cells were cultured in 
complete medium or 0.1mM glutamine medium with or without global 
histone methylation inhibitors (a) or H3K9 specific methylation inhibitors 
(b) for 4 days; histones were extracted and protein levels were assessed by 
western blotting. Total histone H3 was used as loading control. Unprocessed 
original scans of blots are shown in Supplementary Fig. 8. (c) M229 cells 
were cultured in complete medium or 0.1mM glutamine medium with or 
without H3K27 methylation inhibitor EPZ005687 for 4 days, whole cell 
lysates were collected and protein levels were assessed by western blotting. 
Unprocessed original scans of blots are shown in Supplementary Fig. 8. (d) 
M229 and (e) M249 cells were cultured in complete medium or 0.1mM 
glutamine medium with or without H3K27 specific methylation inhibitor 
EPZ005687 for 4 days, then RNA was extracted and gene expression was 
assessed by qPCR. Data represent mean ± S.D. of three independent RNA 
extracts.  **P<.01, ***P<.001 by Student’s t-test.
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Supplementary Figure 6.  Ectopic EZH2 expression rescues the EZH2 shRNA effects. 
EZH2 cDNA: - - +
shEZH2-18365: - + +
Actin
EZH2
EZH2 cDNA: - - +
shEZH2-40076: - + +
Actin
EZH2
a
CD271
Actin
Gln (mM): 4 0.1 4 0.1 4 0.1
EZH2 cDNA: - - - - + +
H3K27me3
H3
shEZH2-40076: - - + + + +
CD271
Actin
Gln (mM): 4 0.1 4 0.1 4 0.1
EZH2 cDNA: - - - - + +
H3K27me3
H3
shEZH2-18365: - - + + + +
b
93
42
18
18
93
42
M, (K)M, (K)
72
42
M, (K)
18
18
72
42
M, (K)
Supplementary Figure 6 Ectopic EZH2 expression rescues the EZH2 shRNA 
effects. (a) EZH2 was knocked down with two different shRNAs in M229 
cells, then the cells were transiently transfected with EZH2 cDNA. Cells 
were harvested after 4 days and EZH2 protein was measured by western 
blotting. Actin was used as loading control. (b) EZH2 was knocked down 
with two different shRNAs in M229 cells, then the cells were transiently 
transfected with EZH2 cDNA in the medium with 4mM or 0.1mM Gln. Cells 
were harvested after 4 days, EZH2 protein and H3K27me3 were assayed 
by western blotting. Total H3 and Actin were used as loading control. 
Unprocessed original scans of blots are shown in Supplementary Fig. 8.
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Supplementary Figure 7. HIF-1α or DNA methylation is not involved in low glutamine-induced CD271 expression.  
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Supplementary Figure 7 Neither HIF-1α nor DNA methylation is involved in low 
glutamine-induced epigenetic modification. (a) M229 cells were transfected 
with HIF-1α siRNA in a 6-well plate at day 1. At day 6, cells were lysed to 
collect whole cell lysate and HIF-1α level was assessed by western blotting. 
Actin was used as loading control. Unprocessed original scans of blots are 
shown in Supplementary Fig. 8. (b) M229 cells were transfected with HIF-1α 
siRNA in a 6-well plate at day 1. From day 2, cells were cultured in complete 
(4mM Gln) or 0.1mM Gln medium for 4 days. At day 6, cells were harvested for 
histone extraction or whole cell lysate collection. Histone lysine methylation and 
protein levels were assessed by western blotting. Total histone H3 and Actin 
were used as loading control. Unprocessed original scans of blots are shown 
in Supplementary Fig. 8. (c) M229 cells were cultured in complete or 0.1mM 
glutamine medium for 4 days, then DNA was extracted and used for whole 
genome DNA methylation sequencing. Methylation status of detected CpG 
sites (density) is shown. (d) M229 cells were cultured in complete medium, 
0.1mM glutamine medium with or without histone methylation inhibitor Adox, 
DNA methylation inhibitors 5-Azacytidine and 5-Aza-2′-deoxycytidine. RNA 
and protein were harvested after 4 days for qPCR (left) and western blotting 
(right). PCR data represent mean ± S.D. of three independent experiments. 
Unprocessed original scans of blots are shown in Supplementary Fig. 8.
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Figure 1d MDA-MB-231
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Supplementary Figure 8 Unprocessed blots of all figures. Black boxes indicate cropped portions that appear in the figures.
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Supplementary Table Legends
Supplementary Table 1 Amino acid concentrations in tumour periphery and core regions.  M229 xenograft tumours were harvested and separated into 
periphery and core samples (n=8 tumours). Metabolites were extracted from each sample and used for LC-MS analysis.  Core/periphery ratio of each amino 
acid was shown.  p value was calculated by Student’s t-test.
Supplementary Table 2 Sequences of primers used in the study.
Supplementary Table 3 Information on antibodies used in the study.
Supplementary Table 4 Statistic source data.
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